Molecular epidemiology and resistance profiles of Clostridium difficile in a tertiary care hospital in Spain

International Journal of Medical Microbiology

Volumn 303, Issue 3, 2013, Pages 128-133

  Weber, Irene ^a   Riera, Elena ^a   Déniz, Candi ^a   Pérez, José L ^a   Oliver, Antonio ^a   Mena, Ana ^a  

^a HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

Author keywords

Antimicrobial resistance; Clostridium difficile infection; MLST; PCR ribotyping; Surveillance; Toxin profile

Indexed keywords

ERYTHROMYCIN; METRONIDAZOLE; MOXIFLOXACIN; VANCOMYCIN;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CLOSTRIDIUM DIFFICILE; ENZYME IMMUNOASSAY; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PHYLOGENY; POLYMERASE CHAIN REACTION; PREVALENCE; RIBOTYPING; SPAIN; TERTIARY HEALTH CARE;

ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; GENOTYPE; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; SPAIN; TERTIARY CARE CENTERS;

EID: 84875932956     PISSN: 14384221     EISSN: 16180607     Source Type: Journal    
DOI: 10.1016/j.ijmm.2013.02.016     Document Type: Article

References (43)

1. Alcalá L., Marín M., Martín A., Sánchez-Somolinos M., Catalán P., Peláez M.T., Bouza E. Laboratory diagnosis of Clostridium difficile infection in Spain: a population-based survey. J. Hosp. Infect. 2011, 79(1):13-17. Spanish Clostridium difficile Study Group.
2. Baines S.D., O'Connor R., Freeman J., Fawley W.N., Harmanus C., Mastrantonio P., Kuijper E.J., Wilcox M.H. Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J. Antimicrob. Chemother. 2008, 62(5):1046-1052.
3. Barbut F., Mastrantonio P., Delmée M., Brazier J., Kuijper E., Poxton I. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterization of the isolates. Clin. Microbiol. Infect. 2007, 13(11):1048-1057. European Study Group on Clostridium difficile (ESGCD).
4. Bauer M.P., Notermans D.W., van Benthem B.H., Brazier J.S., Wilcox M.H., Rupnik M., Monnet D.L., van Dissel J.T., Kuijper E.J. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011, 377(9759):63-73. ECDIS Study Group.
5. Bidet P., Barbut F., Lalande V., Burghoffer B., Petit J.C. Development of a new PCR-ribotyping method for Clostridium difficile based on ribosomal RNA gene sequencing. FEMS Microbiol. Lett. 1999, 175(2):261-266.
6. Bourgault A.M., Lamothe F., Loo V.G., Poirier L. In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada. Antimicrob. Agents Chemother. 2006, 50(10):3473-3475. CDAD-CSI Study Group.
7. Bouza E., Martin A., Van den Berg R.J., Kuijper E.J. Laboratory-acquired Clostridium difficile polymerase chain reaction ribotype 027: a new risk for laboratory workers?. Clin. Infect. Dis. 2008, 47(11):1493-1494.
8. Braun V., Hundsberger T., Leukel P., Sauerborn M., von Eichel-Streiber C. Definition of the single integration site of the pathogenicity locus in Clostridium difficile. Gene 1996, 181(1-2):29-38.
9. Clabots C.R., Johnson S., Bettin K.M., Mathie P.A., Mulligan M.E., Schaberg D.R., Peterson L.R., Gerding D.N. Development of a rapid and efficient restriction endonuclease analysis typing system for Clostridium difficile and correlation with other typing systems. J. Clin. Microbiol. 1993, 31(7):1870-1875.
10. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing; Twenty Second Informational Supplement, M100-S22 2011, CLSI, Wayne, PA, USA.
11. Dingle K.E., Griffiths D., Didelot X., Evans J., Vaughan A., Kachrimanidou M., Stoesser N., Jolley K.A., Golubchik T., Harding R.M., Peto T.E., Fawley W., Walker A.S., Wilcox M., Crook D.W. Clinical Clostridium difficile: clonality and pathogenicity locus diversity. PLoS ONE 2011, 6(5):e19993.
12. Drudy D., Kyne L., O'Mahony R., Fanning S. gyrA mutations in fluoroquinolone-resistant Clostridium difficile PCR-027. Emerg. Infect. Dis. 2007, 13(3):504-505.
13. Dubberke E.R., Nyazee H.A., Yokoe D.S., Mayer J., Stevenson K.B., Mangino J.E., Khan Y.M., Fraser V.J. Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities. Infect. Control Hosp. Epidemiol. 2012, 33(3):305-308.
14. Geric B., Rupnik M., Gerding D.N., Grabnar M., Johnson S. Distribution of Clostridium difficile variant toxinotypes and strains with binary toxin genes among clinical isolates in an American hospital. J. Med. Microbiol. 2004, 53(Pt 9):887-894.
15. Geric B., Carman R.J., Rupnik M., Genheimer C.W., Sambol S.P., Lyerly D.M., Gerding D.N., Johnson S. Binary toxin-producing, large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J. Infect. Dis. 2006, 193(8):1143-1150.
16. Goorhuis A., Bakker D., Corver J., Debast S.B., Harmanus C., Notermans D.W., Bergwerff A.A., Dekker F.W., Kuijper E.J. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 2008, 47(9):1162-1170.
17. Griffiths D., Fawley W., Kachrimanidou M., Bowden R., Crook D.W., Fung R., Golubchik T., Harding R.M., Jeffery K.J., Jolley K.A., Kirton R., Peto T.E., Rees G., Stoesser N., Vaughan A., Walker A.S., Young B.C., Wilcox M., Dingle K.E. Multilocus sequence typing of Clostridium difficile. J. Clin. Microbiol. 2010, 48(3):770-778.
18. Ilchmann C., Zaiss N.H., Speicher A., Christner M., Ackermann G., Rohde H. Comparison of resistance against erythromycin and moxifloxacin, presence of binary toxin gene and PCR ribotypes in Clostridium difficile isolates from 1990 and 2008. Eur. J. Clin. Microbiol. Infect. Dis. 2010, 29(12):1571-1573.
19. Kato N., Ou C.Y., Kato H., Bartley S.L., Brown V.K., Dowell V.R., Ueno K. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J. Clin. Microbiol. 1991, 29(1):33-37.
20. Kato H., Kato N., Watanabe K., Ueno K., Ushijima H., Hashira S., Abe T. Application of typing by pulsed-field gel electrophoresis to the study of Clostridium difficile in a neonatal intensive care unit. J. Clin. Microbiol. 1994, 32(9):2067-2070.
21. Knetsch C.W., Terveer E.M., Lauber C., Gorbalenya A.E., Harmanus C., Kuijper E.J., Corver J., van Leeuwen H.C. Comparative analysis of an expanded Clostridium difficile reference strain collection reveals genetic diversity and evolution through six lineages. Infect. Genet. Evol. 2012, 12(7):1577-1585.
22. Lessa F.C., Gould C.V., McDonald L.C. Current status of Clostridium difficile infection epidemiology. Clin. Infect. Dis. 2012, 55(Suppl. 2):S65-S70.
23. Liao C.H., Ko W.C., Lu J.J., Hsueh P.R. Characterizations of clinical isolates of Clostridium difficile by toxin genotypes and by susceptibility to 12 antimicrobial agents, including fidaxomicin (OPT-80) and rifaximin: a multicenter study in Taiwan. Antimicrob. Agents Chemother. 2012, 56(7):3943-3949.
24. Loo V.G., Poirier L., Miller M.A., Oughton M., Libman M.D., Michaud S., Bourgault A.M., Nguyen T., Frenette C., Kelly M., Vibien A., Brassard P., Fenn S., Dewar K., Hudson T.J., Horn R., René P., Monczak Y., Dascal A. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 2005, 353(23):2442-2449.
25. Manzoor S.E., Tanner H.E., Marriott C.L., Brazier J.S., Hardy K.J., Platt S., Hawkey P.M. Extended multilocus variable-number tandem-repeat analysis of Clostridium difficile correlates exactly with ribotyping and enables identification of hospital transmission. J. Clin. Microbiol. 2011, 49(10):3523-3530.
26. Marsh J.W., O'Leary M.M., Shutt K.A., Pasculle A.W., Johnson S., Gerding D.N., Muto C.A., Harrison L.H. Multilocus variable-number tandem-repeat analysis for investigation of Clostridium difficile transmission in Hospitals. J. Clin. Microbiol. 2006, 44(7):2558-2566.
27. McDonald L.C., Coignard B., Dubberke E., Song X., Horan T., Kutty P.K. Recommendations for surveillance of Clostridium difficile-associated disease. Infect. Control Hosp. Epidemiol. 2007, 28(2):140-145. Ad Hoc Clostridium difficile Surveillance Working Group.
28. Metcalf D.S., Weese J.S. Binary toxin locus analysis in Clostridium difficile. J. Med. Microbiol. 2011, 60(Pt 8):1137-1145.
29. Peláez T., Cercenado E., Alcalá L., Marín M., Martín-López A., Martínez-Alarcón J., Catalán P., Sánchez-Somolinos M., Bouza E. Metronidazole resistance in Clostridium difficile is heterogeneous. J. Clin. Microbiol. 2008, 46(9):3028-3032.
30. Pituch H., van Leeuwen W., Maquelin K., Wultańska D., Obuch-Woszczatyński P., Nurzyńska G., Kato H., Reijans M., Meisel-Mikołajczyk F., Łuczak M., van Belkum A. Toxin profiles and resistances to macrolides and newer fluoroquinolones as epidemicity determinants of clinical isolates of Clostridium difficile from Warsaw, Poland. J. Clin. Microbiol. 2007, 45(5):1607-1610.
31. Pituch H., Obuch-Woszczatyński P., Wultańska D., Nurzyńska G., Harmanus C., Banaszkiewicz A., Radzikowski A., Łuczak M., van Belkum A., Kuijper E. Characterization and antimicrobial susceptibility of Clostridium difficile strains isolated from adult patients with diarrhoea hospitalized in two university hospitals in Poland, 2004-2006. J. Med. Microbiol. 2011, 60(Pt 8):1200-1205.
32. Popoff M.R., Rubin E.J., Gill D.M., Boquet P. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect. Immun. 1988, 56(9):2299-2306.
33. Sánchez-Somolinos M., Alcalá L., Peláez T., Marín M., Martín A., Catalán P., Bouza E. High levels of resistance to fluoroquinolones among Clostridium difficile isolates in a Spanish hospital. Clin. Infect. Dis. 2008, 47(6):818-822.
34. Schneeberg A., Rupnik M., Neubauer H., Seyboldt C. Prevalence and distribution of Clostridium difficile PCR ribotypes in cats and dogs from animal shelters in Thuringia, Germany. Anaerobe 2012, 18(5):484-488.
35. Søes L.M., Brock I., Persson S., Simonsen J., Pribil Olsen K.E., Kemp M. Clinical features of Clostridium difficile infection and molecular characterization of the isolated strains in a cohort of Danish hospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31(2):185-192.
36. Solomon K., Fanning S., McDermott S., Murray S., Scott L., Martin A., Skally M., Burns K., Kuijper E., Fitzpatrick F., Fenelon L., Kyne L. PCR ribotype prevalence and molecular basis of macrolide-lincosamide-streptogramin B (MLSB) and fluoroquinolone resistance in Irish clinical Clostridium difficile isolates. J. Antimicrob. Chemother. 2011, 66(9):1976-1982.
37. Spigaglia P., Barbanti F., Mastrantonio P. Multidrug resistance in European Clostridium difficile clinical isolates. J. Antimicrob. Chemother. 2011, 66(10):2227-2234. European Study Group on Clostridium difficile (ESGCD).
38. Stubbs S.L., Brazier J.S., O'Neill G.L., Duerden B.I. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J. Clin. Microbiol. 1999, 37(2):461-463.
39. Stubbs S., Rupnik M., Gibert M., Brazier J., Duerden B., Popoff M. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol. Lett. 2000, 186(2):307-312.
40. Taori S.K., Hall V., Poxton I.R. Changes in antibiotic susceptibility and ribotypes in Clostridium difficile isolates from southern Scotland, 1979-2004. J. Med. Microbiol. 2010, 59(Pt 3):338-344.
41. Walker A.S., Eyre D.W., Wyllie D.H., Dingle K.E., Harding R.M., O'Connor L., Griffiths D., Vaughan A., Finney J., Wilcox M.H., Crook D.W., Peto T.E. Characterization of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med. 2012, 9(2):e1001172.
42. Warny M., Pepin J., Fang A., Killgore G., Thompson A., Brazier J., Frost E., McDonald L.C. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005, 366(9491):1079-1084.
43. Weese J.S., Avery B.P., Rousseau J., Reid-Smith R.J. Detection and enumeration of Clostridium difficile spores in retail beef and pork. Appl. Environ. Microbiol. 2009, 75(15):5009-5011.